New York-based American Express Company (AXP) is an integrated payments company operating through U.S. Consumer Services, ...

"At bottom, the [integrated savings program] is an invitation to PBMs to engage in price fixing." The pharmacy benefit ...

Cencora simplifies distribution logistics by shipping products to centralized wholesaler locations, as opposed to shipping directly to pharmacies and various customer locations. Additionally, Cencora ...

Independent pharmacies have filed 3 class action lawsuits against GoodRx Holdings and major pharmacy benefit managers (PBMs).

Value investors love finding good stocks at good prices, especially before the broader market catches on to a stock's true value ... Cigna completed its combination with Express Scripts Holding ...

Combining with Express Scripts gave Cigna more tools to help clients control their healthcare costs, and we see significant cross-selling opportunities across their respective books of business. Cigna ...

Cigna (CI) stock gained as company beats Q3 forecasts , driven by Evernorth unit's performance: adjusted income up 5% YoY to $2.1B, revenue at $63.7B. Read more here.

In recent trading, shares of American Express Co. (Symbol: AXP) have crossed above the average analyst 12-month target price of $268.85, changing hands for $271.47/share. When a stock reaches the ...

Shop prices continued to ease in October amid warnings they remain vulnerable to ongoing geopolitical tensions, climate change and Government regulation. Overall prices dropped by 0.8% compared to ...

Nuvama downgraded the stock to a 'hold', cutting FY25E and FY26E EBITDAR by 14 per cent and 7 per cent, respectively. The brokerage firm has a target price of ₹4,415. "Following a 108–133 per ...

American Express has a market capitalization of $189.14 billion. Buying $1000 In AXP: If an investor had bought $1000 of AXP stock 15 years ago, it would be worth $7,574.17 today based on a price ...

Markets are witnessing a healthy consolidation due to FPI selling, geopolitical uncertainty, subdued Q2FY25 results, removal ...